Eurizon SLJ Capital Ltd Invests $10.13 Million in Agilent Technologies, Inc. $A

Eurizon SLJ Capital Ltd purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, Holdings Channel reports. The firm purchased 76,249 shares of the medical research company’s stock, valued at approximately $10,128,000. Agilent Technologies makes up 3.7% of Eurizon SLJ Capital Ltd’s portfolio, making the stock its 9th largest position.

A number of other large investors have also made changes to their positions in A. Fiduciary Trust Co boosted its holdings in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares in the last quarter. Sapient Capital LLC increased its stake in shares of Agilent Technologies by 4.2% in the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after acquiring an additional 85 shares in the last quarter. Plan A Wealth LLC increased its stake in shares of Agilent Technologies by 3.2% in the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after acquiring an additional 92 shares in the last quarter. IHT Wealth Management LLC lifted its position in Agilent Technologies by 4.9% during the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares during the period. Finally, KPP Advisory Services LLC boosted its stake in Agilent Technologies by 2.4% during the second quarter. KPP Advisory Services LLC now owns 4,382 shares of the medical research company’s stock worth $582,000 after acquiring an additional 103 shares in the last quarter.

Agilent Technologies Price Performance

Shares of A opened at $148.55 on Friday. The company has a market capitalization of $41.95 billion, a P/E ratio of 29.83, a price-to-earnings-growth ratio of 2.64 and a beta of 1.25. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The firm has a 50 day moving average of $135.38 and a 200 day moving average of $125.56.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter last year, the company earned $1.31 EPS. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on A. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. TD Cowen upped their price target on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Barclays raised their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Finally, Wells Fargo & Company dropped their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.